Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Bluebird Bio (BLUE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,652,808
  • Shares Outstanding, K 54,160
  • Annual Sales, $ 35,430 K
  • Annual Income, $ -335,640 K
  • 36-Month Beta 1.86
  • Price/Sales 214.02
  • Price/Cash Flow N/A
  • Price/Book 5.10

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 19 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate -2.84
  • Number of Estimates 11
  • High Estimate -2.42
  • Low Estimate -3.23
  • Prior Year -1.73
  • Growth Rate Est. (year over year) -64.16%

Price Performance

See More
Period Period Low Period High Performance
1-Month
134.50 +5.06%
on 09/18/18
176.55 -19.97%
on 08/31/18
-16.70 (-10.57%)
since 08/17/18
3-Month
134.50 +5.06%
on 09/18/18
189.31 -25.36%
on 06/21/18
-36.50 (-20.53%)
since 06/19/18
52-Week
119.90 +17.85%
on 10/02/17
236.17 -40.17%
on 03/13/18
+11.00 (+8.44%)
since 09/19/17

Most Recent Stories

More News
SmarTrend Watching for Potential Rebound in Shares of Bluebird Bio Inc After 5.84% Loss

Bluebird Bio Inc (NASDAQ:BLUE) traded in a range yesterday that spanned from a low of $140.85 to a high of $152.15. Yesterday, the shares fell 5.8%, which took the trading range below the 3-day low of...

BLUE : 141.30 (+0.93%)
Upcoming Earnings to Watch: KR, PLAY, TLRD

Will any of the earnings reports coming in the next few days have enough positive news to outweigh other headwinds? Let's take a closer look.

PLAY : 63.93 (+0.30%)
BLUE : 141.30 (+0.93%)
KR : 28.88 (-1.40%)
TLRD : 24.94 (-0.56%)
AMZN : 1,926.42 (-0.75%)
bluebird (BLUE) Reports Updated Data on Lenti-D Gene Therapy

bluebird bio (BLUE) announces updated results from phase II/III Starbeam study of its Lenti-D gene therapy in boys aged 17 years or below with CALD.

CELG : 87.38 (-0.26%)
LGND : 264.18 (-0.58%)
BLUE : 141.30 (+0.93%)
GILD : 73.88 (+0.29%)
Watch for Bluebird Bio Inc to Potentially Pullback After Gaining 3.01% Yesterday

Bluebird Bio Inc (NASDAQ:BLUE) traded in a range yesterday that spanned from a low of $170.50 to a high of $176.15. Yesterday, the shares gained 3.0%, which took the trading range above the 3-day high...

BLUE : 141.30 (+0.93%)
O Canada...We're Waiting On You

O Canada...We're Waiting On You

NVMI : 26.06 (-0.38%)
EVTC : 23.45 (+0.21%)
CRSP : 51.89 (-2.43%)
WK : 35.00 (-2.51%)
BLUE : 141.30 (+0.93%)
RDWR : 25.37 (-1.25%)
bluebird bio to Present at Investor Conferences in September

bluebird bio, Inc. (Nasdaq: BLUE) today announced that members of the management team will present at the following upcoming investor conferences:

BLUE : 141.30 (+0.93%)
bluebird bio and Gritstone Oncology Announce Strategic Collaboration to Develop Novel Cancer Cell Therapies

bluebird bio, Inc. (Nasdaq: BLUE) and Gritstone Oncology, Inc. today announced a collaboration to research, develop and commercialize products for the treatment of cancer using cell...

BLUE : 141.30 (+0.93%)
Is Celgene Set to See Improved Results in the Second Half?

After a series of pipeline setbacks, things are looking better for biotech bigwig Celgene (CELG) with positive data read-outs and an increase in guidance.

CELG : 87.38 (-0.26%)
BLUE : 141.30 (+0.93%)
XLRN : 56.34 (+4.28%)
PRTA : 13.36 (+1.14%)
Turkey Ruins Week for Dow, S&P

Turkey Ruins Week for Dow, S&P

HUBG : 47.65 (-1.14%)
A : 69.56 (+0.91%)
R : 75.44 (-0.33%)
WAL : 57.69 (+1.14%)
ONCE : 56.63 (-2.46%)
AVLR : 43.49 (-0.14%)
BLUE : 141.30 (+0.93%)
PGR : 69.88 (+0.29%)
DWDP : 68.73 (+1.03%)
Biotech Stock Roundup: Regeneron Shines, BLUE Surges, ONCE Plunges

The last leg of Q2 earnings in the biotech sector saw Regeneron firing all cylinders. The company also collaborated with bluebird bio, which impressed investors.

ONCE : 56.63 (-2.46%)
BLUE : 141.30 (+0.93%)
VRTX : 176.60 (-0.29%)
GILD : 73.88 (+0.29%)
REGN : 383.70 (-1.19%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade BLUE with:

Business Summary

Bluebird Bio, Inc. is a biotechnology company. It focuses on the development, manufacture and marketing of therapies for severe genetic disorders such as childhood cerebral adrenoleukodystrophy, neurodegenerative disorders and beta-thalassemia. The company operates in the U.S. and Europe. Bluebird Bio,...

See More

Key Turning Points

2nd Resistance Point 144.56
1st Resistance Point 142.93
Last Price 141.30
1st Support Level 139.39
2nd Support Level 137.47

See More

52-Week High 236.17
Fibonacci 61.8% 191.75
Fibonacci 50% 178.03
Fibonacci 38.2% 164.31
Last Price 141.30
52-Week Low 119.90

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar